Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times
Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery
Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT
Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response Statistics in Medicine
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis BMC Cancer
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine
A review of neurotoxicities associated with immunotherapy and a framework for evaluation Neuro-Oncology Advances
Nonparametric tests for multistate processes with clustered data AISM
The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study Contemporary Clinical Trials Communications
PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients Frontiers in Immunology
Leveraging external data in the design and analysis of clinical trials in neuro-oncology Lancet Oncology
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma American Association for Cancer Research